Publications by authors named "Sue Robinson"

Claim this Profile
C
Contemporary Fixed-Duration Treatment Options in the First-Line Setting of Chronic Lymphocytic Leukemia: Perspectives from a Publicly Funded Healthcare System.
Christopher Lemieux, Chai W Phua, K Sue Robinson, Carolyn Owen, Versha Banerji

Curr Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a Virtual Home Health Heart Failure Program: Mixed Methods Study.
Nilufeur McKay, Rosemary Saunders, Helene Metcalfe, Sue Robinson, Peter Palamara

JMIR Cardio· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre-autologous stem cell transplant in relapsed/refractory diffuse large B-cell lymphoma-outcome of rituximab-dose-intensive cyclophosphamide, etoposide, cisplatin (R-DICEP) versus R-GDP.
Douglas A Stewart, John Kuruvilla, David Lee, Jill J Dudebout, Neil Chua, Sue Robinson

Br J Haematol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management and use of healthcare resources in patients with chronic lymphocytic leukemia initiating venetoclax in routine clinical practice.
Versha Banerji, Andrew Aw, Nicole Laferriere, Nizar Abdel-Samad, Anthea Peters, Sue Robinson

Leuk Lymphoma· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian evidence-based guideline for treatment of relapsed/refractory chronic lymphocytic leukemia.
Carolyn Owen, Sarah Eisinga, Versha Banerji, Nathalie Johnson, Alina S Gerrie, Sue Robinson

Leuk Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interactive technology use and child development: A systematic review.
Diana Arabiat, Mohammad Al Jabery, Sue Robinson, Lisa Whitehead, Evalotte Mörelius

Child Care Health Dev· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining ferritin clinical decision limits to improve diagnosis and treatment of iron deficiency: A modified Delphi study.
Kanza Naveed, Nicola Goldberg, Eliane Shore, Arti Dhoot, Denise Gabrielson, Sue Robinson

Int J Lab Hematol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Canadian evidence-based guideline for frontline treatment of chronic lymphocytic leukemia: 2022 update" [Leukemia Research 125 (2023) 107016].
Carolyn Owen, Versha Banerji, Nathalie Johnson, Alina Gerrie, Andrew Aw, Sue Robinson

Leuk Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian evidence-based guideline for frontline treatment of chronic lymphocytic leukemia: 2022 update.
Carolyn Owen, Versha Banerji, Nathalie Johnson, Alina Gerrie, Andrew Aw, Sue Robinson

Leuk Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using genetic analysis to determine the distribution, prevalence and diversity of Eimeria species in pest rabbits (Oryctolagus cuniculus) in Australia.
David Peacock, Adam Croxford, Amy Iannella, John Kovaliski, Antonio Lavazza, Sue Robinson

Parasitol Int· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cdk1-mediated threonine phosphorylation of Sam68 modulates its RNA binding, alternative splicing activity and cellular functions.
Idir Malki, Inara Liepina, Nora Kogelnik, Hollie Watmuff, Sue Robinson

Nucleic Acids Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Canadian Perspective: Monoclonal Antibodies for Pre- and Post-Exposure Protection from COVID-19 in Vulnerable Patients with Hematological Malignancies.
Carolyn Owen, Sue Robinson, Anna Christofides, Laurie H Sehn

Curr Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of extended half-life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B.
Haowei Linda Sun, Ming Yang, Man-Chiu Poon, Adrienne Lee, K Sue Robinson

Res Pract Thromb Haemost· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factor product utilization and health outcomes in patients with haemophilia A and B on extended half-life concentrates: A Canadian observational study of real-world outcomes.
Haowei Linda Sun, Ming Yang, Man-Chiu Poon, Adrienne Lee, K Sue Robinson

Haemophilia· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study.
Stephan Stilgenbauer, Francesc Bosch, Osman Ilhan, Jens Kisro, Béatrice Mahé, Sue Robinson

Br J Haematol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of neuroinflammatory nitric oxide signaling suppresses glycation and prevents neuronal dysfunction in mouse prion disease.
Julie-Myrtille Bourgognon, Jereme G Spiers, Sue W Robinson, Hannah Scheiblich, Paul Glynn

Proc Natl Acad Sci U S A· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial.
Othman Al-Sawaf, Can Zhang, Maneesh Tandon, Arijit Sinha, Anna-Maria Fink, Sue Robinson

Lancet Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IND.216: a phase II study of buparlisib and associated biomarkers, raptor and p70S6K, in patients with relapsed and refractory chronic lymphocytic leukemia.
Sarit Assouline, Lilian Amrein, Raquel Aloyz, Versha Banerji, Stephen Caplan, Sue Robinson

Leuk Lymphoma· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The conditional survival analysis of relapsed DLBCL after autologous transplant: a subgroup analysis of LY.12 and CORAL.
Sarit Assouline, Shen Li, Christian Gisselbrecht, Patrick Fogarty, Annette Hay, Sue Robinson

Blood Adv· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An overview of inherited factor VII deficiency.
K Sue Robinson

Transfus Apher Sci· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stomach contents of long-finned pilot whales, Globicephala melas mass-stranded in Tasmania.
Isabel Beasley, Yves Cherel, Sue Robinson, Emma Betty, Rie Hagihara

PLoS One· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions.
Kirsten Fischer, Othman Al-Sawaf, Jasmin Bahlo, Anna-Maria Fink, Maneesh Tandon, Sue Robinson

N Engl J Med· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Nrf2/Keap1 Mediated Redox Signaling Supports Synaptic Function and Longevity and Impacts on Circadian Activity.
Jereme G Spiers, Carlo Breda, Sue Robinson, Flaviano Giorgini, Joern R Steinert

Front Mol Neurosci· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance).
John C Byrd, Amy S Ruppert, Nyla A Heerema, Alese E Halvorson, Eva Hoke, Sue Robinson

Blood Adv· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax and obinutuzumab in chronic lymphocytic leukemia.
Kirsten Fischer, Othman Al-Sawaf, Anna-Maria Fink, Mark Dixon, Jasmin Bahlo, Sue Robinson

Blood· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis